TG Therapeutics, Inc.
TGTX
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
TG Therapeutics is a biotechnology company that develops and commercializes treatments for B-cell malignancies and autoimmune diseases. The company’s drug development pipeline relies on preclinical animal testing to satisfy regulatory requirements for safety and efficacy. Its SEC filings acknowledge that operations are subject to the federal Animal Welfare Act and that animal rights groups have targeted the company and its industry peers.
The company is listed by Cruelty Free Investors among firms that exploit animals, specifically under an “Animal Usage: Animal Testing” designation. This indicates its research and development processes incorporate animal models as a standard practice. While the precise scale of its animal testing operations is not detailed in public financial documents, the company’s business model is inherently dependent on animal data to advance therapeutic candidates through clinical trials.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.